Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Agnes Morel"'
Publikováno v:
Clinical Nuclear Medicine
Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2020, 45, pp.e403-e405. ⟨10.1097/rlu.0000000000003178⟩
Clinical Nuclear Medicine, 2020, 45, pp.e403-e405. ⟨10.1097/rlu.0000000000003178⟩
Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2020, 45, pp.e403-e405. ⟨10.1097/rlu.0000000000003178⟩
Clinical Nuclear Medicine, 2020, 45, pp.e403-e405. ⟨10.1097/rlu.0000000000003178⟩
International audience; Radiation pneumonitis (RP) can be an adverse complication of radiotherapy and usually occurs as an acute reaction from 6 to 12 weeks after radiotherapy. FDG PET is described as an early and adequate barometer for RP diagnosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67cd68b33ca4de3151bdfd7c1c667c1
https://www.hal.inserm.fr/inserm-03006971/file/Morel2020Eq13.pdf
https://www.hal.inserm.fr/inserm-03006971/file/Morel2020Eq13.pdf
Autor:
Ludovic Ferrer, Emilie Debeaupuis, Nicolas Varmenot, Agnes Morel, Françoise Kraeber-Bodéré, Antoine Denis, D. Rusu, Loïc Campion, Maelle Le Thiec, Caroline Rousseau, Pierre Baumgartner, Mathieu Frindel, Aurore Rauscher, Bruno Maucherat, Vincent Fleury
Publikováno v:
The Prostate.
BACKGROUND In this prospective study (NCT03443609), we investigated the impact of 68Ga-PSMA-11 PET-CT on the treatment plan and therapeutic response obtained for patients with prostate cancer (PCa) presenting a recurrence with a low rising PSA. METHO
Autor:
Caroline, Rousseau, Maelle, Le Thiec, Ludovic, Ferrer, Daniela, Rusu, Aurore, Rauscher, Bruno, Maucherat, Mathieu, Frindel, Pierre, Baumgartner, Vincent, Fleury, Antoine, Denis, Agnes, Morel, Nicolas, Varmenot, Emilie, Debeaupuis, Loic, Campion, Francoise, Kraeber-Bodéré
Publikováno v:
The Prostate. 79(13)
In this prospective study (NCT03443609), we investigated the impact of 68Ga-PSMA-11 PET-CT on the treatment plan and therapeutic response obtained for patients with prostate cancer (PCa) presenting a recurrence with a low rising PSA.One hundred thirt